Question 1

What are the expected benefits of switching to risperidone from my current medication?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Efficacy Study of Early Onset of Antipsychotic Drug Action in Schizophrenia clinical trial (NCT00337662). Contact the study team or your healthcare provider for specific answers.

Question 2

How will we monitor my response to the treatment during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Efficacy Study of Early Onset of Antipsychotic Drug Action in Schizophrenia clinical trial (NCT00337662). Contact the study team or your healthcare provider for specific answers.

Question 3

What side effects should I be aware of while taking these medications?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Efficacy Study of Early Onset of Antipsychotic Drug Action in Schizophrenia clinical trial (NCT00337662). Contact the study team or your healthcare provider for specific answers.

Question 4

How does this trial compare to other treatment options available for me?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Efficacy Study of Early Onset of Antipsychotic Drug Action in Schizophrenia clinical trial (NCT00337662). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I experience severe side effects during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Efficacy Study of Early Onset of Antipsychotic Drug Action in Schizophrenia clinical trial (NCT00337662). Contact the study team or your healthcare provider for specific answers.

Question 6

How often will I need to visit for check-ups during the treatment period?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Efficacy Study of Early Onset of Antipsychotic Drug Action in Schizophrenia clinical trial (NCT00337662). Contact the study team or your healthcare provider for specific answers.

What this study is about